MedPath

Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure

Not Applicable
Completed
Conditions
Heart Failure
Sleep Disordered Breathing
Registration Number
NCT00733343
Lead Sponsor
ResMed
Brief Summary

The purpose of this trial is to evaluate the long-term effects and cost-effectiveness of adaptive servo-ventilation (ASV) on the mortality and morbidity of patients with stable heart failure due to left ventricular systolic dysfunction, already receiving optimal medical therapy, who have sleep disordered breathing (SDB) that is predominantly central sleep apnea. Assumptions: the intervention reduces the hazard rate by 20%. The event rate in the control group is 35% in the first year. It is assumed that the hazard rate is constant over time.

Detailed Description

Objective: The purpose of this trial is to evaluate the long-term effects and cost-effectiveness of adaptive servo-ventilation (ASV) on the mortality and morbidity of patients with stable heart failure due to left ventricular systolic dysfunction, already receiving optimal medical therapy, who have sleep disordered breathing (SDB) that is predominantly central sleep apnea.

Study Design: Randomized, multicentre, international trial with parallel group design, with patients randomized to either control (optimal medical management) or active treatment (optimal medical treatment plus use of adaptive servoventilation) in a 1:1 ratio. There will be no sham-positive airway pressure treatment in the control arm. Assumptions: the intervention reduces the hazard rate by 20%. The event rate in the control group is 35% in the first year. It is assumed that the hazard rate is constant over time. The trial is an event driven design: the final analysis is to be performed latest when 651 events have been observed. The primary analysis is in the intention-to-treat population that consists of all patients randomized.

Number of Patients: 1116 patients will be randomly assigned to one of the two treatment groups. A 20% drop out rate is estimated.

Selection criteria: Patients at the age of or over 22 years with severe chronic heart failure (chronic HF), New York Heart Association (NYHA) class III-IV or NYHA class II with at least one hospitalization for HF within the last 24 months, with Left Ventricular Ejection Fraction (LVEF) less or equal 45% by means of echocardiography, radionuclide ventriculography or cardiac MRI and Sleep Disordered Breathing (SDB) (apnoea-hypopnoea-index (AHI \> 15/h) with 50% central events and a central AHI ≥ 10/h, no change of medication and no hospitalization for more than 1 month before randomization and medical therapy according to the applicable guidelines (European Society of Cardiology (ESC) and American College of Cardiology/American Heart Association (ACC/AHA) respectively).

Primary Endpoints: Time to first event of:

1. all cause mortality or unplanned hospitalisation/prolongation of hospitalisation for worsening heart failure

2. cardiovascular mortality or unplanned hospitalisation/prolongation of hospitalisation for worsening heart failure.

3. all cause mortality or all cause unplanned hospitalisation/prolongation of hospitalisation Heart transplantation, appropriate shock from implantable cardioverter-defibrillator (ICD), long term assist device (LTAD) insertion and survived resuscitation of sudden cardiac arrest are counted as cardiovascular death, survived resuscitation for other reasons is counted as all cause death.

The three combinations are not tested in parallel but in this hierarchical order.

Secondary Endpoints : Time until death, non cardiovascular death, cardiovascular death, hospitalization due to deterioration of heart failure or cardiovascular death, hospitalization for other reasons or death, hospitalization for cardiovascular cause or cardiovascular death, percent of follow-up (FU) days which patient survives and is not hospitalized for cardiovascular cause, percent of follow up days which patient survives and is not hospitalized for other reason, time to first adequate shock (in patients with ICD, evaluation of appropriateness will also be made by the ERC) or cardiovascular death, changes in NYHA class as compared to baseline, changes in difference in health costs between the two treatment groups, changes in QoL (Minnesota, Euroqol 5D (EQ5D)) as compared to baseline, changes in renal function (based on serum creatinine) as compared to baseline, changes in result of Six Minute Walking Test (6MWT) (50) as compared to baseline,changes of AHI and oxygen desaturation index compared to baseline, AHI below 10 per hour at twelve months and Oxygen desaturation index (ODI) below 5 per hour at twelve months, atrial fibrillation at follow-up visits.

Number and cost of hospitalizations (with tariff/diagnostic-related Group (DRG), diagnoses and procedures for calculating DRG or length of stay and level of care provided), cost of care (technology and service, nursing, physicians visit) related to ventilation, difference in utilities / QoL (Minnesota and EQ5D) compared to control arm, difference in cost of resources consumed, cost-efficacy, cost-utility. Secondary target parameters will be measured at the last follow up or at the last available observation within FU.

Scheduled follow up : Minimum follow up time will be 24 months, maximum about 70 months. There will be a final assessment for each patient at the end of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1325
Inclusion Criteria
  • Patients must be at least 22 years old
  • Chronic heart failure (at least 12 weeks since diagnosis) according to the current applicable guidelines (ESC, ACC/AHA)
  • Left ventricular systolic dysfunction (LVEF ≤45% by imaging method such as echocardiography, radionuclide angiography, left ventriculography, or cardiac magnetic resonance imaging) documented less than 12 weeks before randomisation
  • NYHA class III or IV at the time of inclusion or NYHA class II with at least one hospitalisation for HF in the last 24 months
  • No hospitalisation for heart failure for at least 4 weeks prior to inclusion
  • Optimised medical treatment according to applicable guidelines with no new class of disease modifying drug for more than 4 weeks prior to randomisation. In case of no beta blockers or ACE (angiotensin converting Enzyme) inhibitors/ ARB (angiotensin receptor blocker) antagonists the reasons must be documented
  • SDB (AHI > 15/h with ≥ 50% central events and a central AHI ≥ 10/h, derived from polygraphy or polysomnography (based on total recording time (TRT)), documented less than 4 weeks before randomisation. Flow measurement has to be performed with nasal cannula
  • Patients for whom the use of AutoSet CS2 (TM)/VPAP Adapt may be contra-indicated because of symptomatic hypotension or significant intravascular volume depletion or pneumothorax or pneumomediastinum
  • Patient is able to fully understand study information and signed informed consent
Exclusion Criteria
  • Significant COPD (chronic obstructive pulmonary disease) with Forced Expiratory Volume within one second (FEV1) <50% (European Respiratory Society criteria) in the last four weeks before randomisation
  • Oxygen saturation at rest during the day ≤ 90% at inclusion
  • Current use of Positive Airway Pressure (PAP) - therapy
  • Life expectancy < 1 year for diseases unrelated to chronic HF
  • Cardiac surgery, Percutaneous coronary intervention (PCI), Myocardial Infarction (MI) or unstable angina within 6 months prior to randomisation
  • CRT (cardiac resynchronisation therapy)-implantation or ICD-implantation scheduled or within 6 months prior to randomisation
  • Transient ischemic attack (TIA) or Stroke within 3 months prior to randomisation
  • Primary hemodynamically significant uncorrected valvular heart disease, obstructive or regurgitant, or any valvular disease expected to lead to surgery during the trial
  • Acute myocarditis/pericarditis within 6 months prior to randomisation
  • Untreated or therapy refractory Restless legs-Syndrome (RLS) according to criteria listed in Appendix IX at the time of study entry
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
All Cause Mortality or Unplanned Hospitalisation/Prolongation of Hospitalisation for Worsening Heart Failuretime to first event, assessed for up to 70 weeks
Cardiovascular Mortality or Unplanned Hospitalisation/Prolongation of Hospitalisation for Worsening Heart Failuretime to first event, assessed for up to 70 weeks
All Cause Mortality or All Cause Unplanned Hospitalisation/Prolongation of Hospitalisationtime to first event, assessed for up to 70 weeks
Secondary Outcome Measures
NameTimeMethod
Death From Any Causethe last follow up or at the last available observation within Follow Up (FU), assessed for up to 70 weeks
First Survived Resuscitation of Sudden Cardiac Arrest (Evaluation Will Also be Made by the ERC)the last follow up or at the last available observation within FU, assessed for up to 70 weeks
Age Baseline1 x at Baseline
Creatinine Baseline1 x at baseline
6-Min Walk Distance1 x at baseline
Epworth Sleepiness Scale (ESS)1 x at baseline

Measure Description: ESS is a self-administered questionnaire. It contains 8 questions. Questions are rated on a 4-point Likert scale (0-3); 0= would never doze, 3=high Chance of dozing. Range of scores 0-24. Global score= sum of all item scores. Copyright (c)MW Johns

Unplanned Hospitalisation/Prolongation of Hospitalisation Due to Worsening of Heart Failurethe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Cardiovascular Deaththe last follow up or at the last available observation within FU, assessed for up to 70 weeks
First Survived Resuscitation for Any Reason (Evaluation Will Also be Made by the ERC)the last follow up or at the last available observation within FU, assessed for up to 70 weeks
Blood Pressure Diastolic Baseline1 x at baseline
Hemoglobine Baseline1 x at baseline
Glomerular Filtration Rate Baseline1 x at baseline
Adequate Shock in Patients With ICD (Evaluation of Appropriateness Will Also be Made by the Endpoint Review Committee, ERC), Long-Term Atrial Defibrillator Insertion or Cardiovascular Deaththe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Body Mass Index (BMI) Baseline1 x baseline
Apnoea-Hypopnea-Index (AHI) at Baseline1 x at baseline

Measure Description: The AHI is an index to describe the severity of Sleep Apnea. Apnea is cessation of breathing during sleep. Hypopnea is diminished breathing during sleep. The number of Apneas and Hypopneas are added up and divided by hours of sleep (Apneas + Hypopneas per hour). An AHI ranging from 5-15 describes mild Sleep Apnea. AHI 15-30 describes moderate Sleep Apnea. AHI \>30 describes severe Sleep Apnea.

Central Apnoea Index/Total AHI1 x at baseline

Measure Description: Central apneas are partial or complete cessations of airflow caused by reduced or stopped neural Stimulation of the breathing muscles. For comparison: In obstructive apneas are caused by blocked airways that shut off the air although the breathing Stimulus is working.

Changes in NYHA Classification as Compared to Baselinethe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Non-cardiovascular Deaththe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Unplanned Hospitalisation/Prolongation of Hospitalisation for Other Reasons or Deaththe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Left Ventricular Ejection Fraction at Baseline1x at baseline
Oxygen Desaturation Index (ODI) at Baseline1 x at baseline

Number of oxygen desaturations per hour at baseline

Time Until Unplanned Hospitalisation/Prolongation of Hospitalisation for Cardiovascular Cause or Cardiovascular Death/ Time Framethe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Percent of Follow up Days Which Patient Survives and is Not Hospitalized/Hospital Stay is Not Prolonged for Cardiovascular Causethe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Changes in QoL (Minnesota) as Compared to Baselinethe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Atrial Fibrillation at Follow-up Visitsthe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Body Weight Baseline1 x at baseline
Blood Pressure Systolic Baseline1 x at baseline
Central AHI/Total AHI at Baseline1 x at baseline
Changes of AHI and Oxygen Desaturation Index Compared to Baselinethe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Oxygen Saturation Baseline1 x at baseline
Time With Oxygen Saturation Below 90%1 x at baseline
Changes in Six Minute Walking Distance (6MWD) as Compared to Baselinethe last follow up or at the last available observation within FU, assessed for up to 70 weeks
AHI Below 10 Per Hour at Twelve Months and ODI Below 5 Per Hour at Twelve Monthsthe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Number and Cost of Hospitalisations (With Tariff/DRG, Diagnoses and Procedures for Calculating DRG or Length of Stay and Level of Care Provided)the last follow up or at the last available observation within FU, assessed for up to 70 weeks
Difference in Utilities / QoL (Minnesota and EQ5D) Compared to Control Armthe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Difference in Cost of Resources Consumedthe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Changes in Renal Function (Based on Serum Creatinine) as Compared to Baselinethe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Incremental Cost-utility Ratiothe last follow up or at the last available observation within FU, assessed for up to 70 weeks
Incremental Cost-efficacy Ratiothe last follow up or at the last available observation within FU, assessed for up to 70 weeks

Trial Locations

Locations (264)

Praxis Westend

🇩🇪

Berlin, Germany

Helsinki University Hospital

🇫🇮

Helsinki, Finland

CHU de Caen

🇫🇷

Caen Cedex, France

Praxis Cardiologique Dr. Wickers

🇫🇷

Bordeaux, France

CH de Forbach, Hospitalor, Hopital Marie Madeleine-Pneumology

🇫🇷

Forbach, France

CHU Grenoble, Hopital Michallon

🇫🇷

Grenoble, France

Hospices Civils de Lyon, Hopital de la Croix-Rousse

🇫🇷

Lyon, France

CH de Mulhouse, Hopital Emile Muller

🇫🇷

Mulhouse, France

CH Rene Dubos

🇫🇷

Pontoise, France

CHU de Nancy, Hopital Brabois

🇫🇷

Vandoeuvre les Nancy, France

Herzzentrum Bad Krozingen

🇩🇪

Bad Krozingen, Germany

Kardiopraxis Rheinberg

🇩🇪

Bergisch Gladbach, Germany

POLIKUM Friedenau

🇩🇪

Berlin, Germany

Praxis für Lunge, Herz und Schlaf

🇩🇪

Bielefeld, Germany

Universitätsklinikum Bergmannsheil

🇩🇪

Bochum, Germany

Augusta Krankenanstalten Bochum

🇩🇪

Bochum, Germany

St.-Josephs-Hospital

🇩🇪

Bochum, Germany

Kardiologische Praxis Dr. Staubach

🇩🇪

Bochum, Germany

Kardiologische Praxis Marschner

🇩🇪

Bonn, Germany

Klinikum Bremen Ost

🇩🇪

Bremen, Germany

Gemeinschaftspraxis Kardiologie

🇩🇪

Bottrop, Germany

Internistenpraxis Alstertal Hamburg

🇩🇪

Hamburg, Germany

Praxis Dr. Anselm Bäumer

🇩🇪

Köln, Germany

Gemeinschaftspraxis Dr. Jocham

🇩🇪

Memmingen, Germany

Kardiologische Praxis Dr. Muradi

🇩🇪

Münster, Germany

Kardiologische Praxis Nienburg

🇩🇪

Nienburg, Germany

Kreiskrankenhaus Stollberg GmbH

🇩🇪

Stollberg, Germany

Missionsärztliche Klinik Würzburg

🇩🇪

Würzburg, Germany

Cardiocentro Ticino

🇨🇭

Lugano, Switzerland

Dansk Center For Søvnmedicin

🇩🇰

Glostrup, Denmark

Krankenhaus Bethanien

🇩🇪

Moers, Germany

CH Belfort

🇫🇷

Belfort, France

CH de Besancon

🇫🇷

Besancon, France

CHU Bordeaux, Hopital Pellegrin

🇫🇷

Bordeaux, France

Clinique Mutualiste des Eaux Claires

🇫🇷

Grenoble, France

Unesta Research Centre

🇫🇮

Tampere, Finland

CHU Angers

🇫🇷

Angers, France

Hopital Prive d'Antony

🇫🇷

Antony, France

Clinique du Tondu

🇫🇷

Bordeaux, France

CH de Forbach-Cardiology

🇫🇷

Forbach, France

CHU Lille-Sleep medicine

🇫🇷

Lille, France

Polyclinique La Louviere

🇫🇷

Lille, France

Kardiologische Praxis Dr. Isbruch

🇩🇪

Castrop-Rauxel, Germany

MECS Cottbus GmbH

🇩🇪

Cottbus, Germany

Hôpital Bichat

🇫🇷

Paris, France

Charité Campus Mitte CCM- Schlafmedizinisches Zentrum

🇩🇪

Berlin, Germany

Centre Hospitalier d'Antibes Juan-les-Pins

🇫🇷

Antibes, France

Hopital Henri Mondor

🇫🇷

Creteil, France

CHU de Montpellier

🇫🇷

Montpellier, France

CHU de Bordeaux, Hopital Haut Leveque

🇫🇷

Pessac, France

Cardiopraxis Ingelheim

🇩🇪

Mainz, Germany

Klinik Lazariterhof

🇩🇪

Bad Krozingen, Germany

Tampere University Hospital, Pirkanmaa sairaanhoitopiiri

🇫🇮

Tampere, Finland

Hôpital Sud

🇫🇷

Echirolles, France

Clinique de L'Union

🇫🇷

L'Union, France

CHU Lille- Hopital Cardiologique

🇫🇷

Lille, France

CHR Metz, Hôpital de Bon-Secours

🇫🇷

Metz, France

Kardiologie Kemnade

🇩🇪

Bochum, Germany

Helios Klinikum Borna

🇩🇪

Borna, Germany

Gemeinschaftspraxis Kardiologie Dr. Becker

🇩🇪

Castrop-Rauxel, Germany

Mediclin Rehazentrum Spreewald

🇩🇪

Burg, Germany

Charité Campus Mitte - Kardiologie

🇩🇪

Berlin, Germany

Hôpital St. André

🇫🇷

Bordeaux, France

Praxis Cardiologique Dr. Puel

🇫🇷

Bordeaux, France

CH Haguenau

🇫🇷

Haguenau, France

Clinique des Trois Frontières

🇫🇷

Saint Louis, France

Zentralklinikum Bad Berka

🇩🇪

Bad Berka, Germany

Schlaflabor Breisgau

🇩🇪

Bad Krozingen, Germany

Universitätsklinikum Bonn

🇩🇪

Bonn, Germany

Kardiologische Praxis Dr. Dröse

🇩🇪

Dortmund, Germany

Gemeinschaftspraxis Dres. Schmidt/Gronke

🇩🇪

Dresden, Germany

Kardiologische Praxis Dr. Kruse

🇩🇪

Forst, Germany

Kardiologische Praxis Dr. Schlichting

🇩🇪

Herne, Germany

Augusta-Kranken-Anstalt gGmbH Thoraxzentrum Ruhrgebiet

🇩🇪

Herne, Germany

Lungenfachklinik Immenhausen

🇩🇪

Immenhausen, Germany

Gemeinschaftspraxis Dres. Dobler/Turin

🇩🇪

Karlstadt, Germany

Helios Klinikum Krefeld

🇩🇪

Krefeld, Germany

Helios Krankenhaus Leisnig

🇩🇪

Leisnig, Germany

Kardiologische Praxis Dr. Faber

🇩🇪

Lindlar, Germany

Cabinet de cardiologie

🇫🇷

Pont-à-mousson, France

Praxis Dr. Frieske

🇩🇪

Aachen, Germany

Universitätsklinikum Aachen

🇩🇪

Aachen, Germany

Praxis Dr. Rau

🇩🇪

Essen, Germany

Universitaetsklinikum Freiburg

🇩🇪

Freiburg im Breisgau, Germany

Gemeinschaftspraxis Dres Leischik/Littwitz

🇩🇪

Hagen, Germany

Kardiologische Praxis Dr. Cierpka

🇩🇪

Hannover, Germany

Ärztezentrum Holthausen-Biene

🇩🇪

Lingen, Germany

Universitätsklinikum Mannheim-Schlafmedizin

🇩🇪

Mannheim, Germany

University Medical Center Groningen

🇳🇱

Groningen, Netherlands

Jüdisches Krankenhaus Berlin

🇩🇪

Berlin, Germany

Asklepios Klinik Barmbek

🇩🇪

Hamburg, Germany

Praxis Dr. Hecker

🇩🇪

Dortmund, Germany

Helios Klinikum Erfurt-Kardiologie

🇩🇪

Erfurt, Germany

Kardiologie Praxis Dr. Bonnekamp

🇩🇪

Essen, Germany

Kardiologische Praxis Dr. Hartung

🇩🇪

Hannover, Germany

Thoraxklinik Heidelberg gGmbH

🇩🇪

Heidelberg, Germany

Lungenklinik Hemer

🇩🇪

Hemer, Germany

St.-Vinzenz Hospital

🇩🇪

Köln, Germany

Universitätsklinikum Leipzig-Herzzentrum

🇩🇪

Leipzig, Germany

Klinikum der Johannes Gutenberg-Universität Mainz

🇩🇪

Mainz, Germany

Universitätsklinikum Münster

🇩🇪

Münster, Germany

Universitätsklinikum Würzburg

🇩🇪

Würzburg, Germany

Unfallkrankenhaus Berlin

🇩🇪

Berlin, Germany

Evangelische Lungenfachklinik Buch

🇩🇪

Berlin, Germany

Charité Campus Virchow Klinikum

🇩🇪

Berlin, Germany

Klinikum Nürnberg Süd

🇩🇪

Nürnberg, Germany

Kardiologische Praxis Dr. Golling

🇩🇪

Dortmund, Germany

Kardiologische Praxis Dr. Horowitz

🇩🇪

Düsseldorf, Germany

Ruhrlandklinik Essen

🇩🇪

Essen, Germany

CardioVasculäres Centrum Frankfurt

🇩🇪

Frankfurt, Germany

Kardiologische Praxis Dr. Arens

🇩🇪

Hagen, Germany

Siloah Krankenhaus

🇩🇪

Hannover, Germany

Ambulantes Herzzentrum Kassel

🇩🇪

Kassel, Germany

Praxis Dr. Krater

🇩🇪

Krefeld, Germany

Kardiologische Praxis Dr. Fritsch

🇩🇪

Köln, Germany

Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie

🇩🇪

Lübeck, Germany

Evangelisches Krankenhaus Mülheim

🇩🇪

Mülheim an der Ruhr, Germany

Clinical Trial Site Services

🇩🇪

Dortmund, Germany

Kardiologische Praxis Gütersloh

🇩🇪

Gütersloh, Germany

MH Hannover

🇩🇪

Hannover, Germany

Kardiologische Praxis Dr. Furche

🇩🇪

Herne, Germany

Klinikum Dahme-Spreewald GmbH

🇩🇪

Königs Wusterhausen, Germany

Kardiologische Praxis Dr. Rudolf/ Dr. Bernhardt

🇩🇪

Worms, Germany

Oslo University Hospital, Rikshospitalet

🇳🇴

Oslo, Norway

Zentrum für Innere Medizin Uni Ulm

🇩🇪

Ulm, Germany

Ullevål University Hospital

🇳🇴

Oslo, Norway

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

Westmead Hospital

🇦🇺

Westmead, New South Wales, Australia

Rivercity Private Hospital

🇦🇺

Auchenflower, Queensland, Australia

St Vincents and Mercy Private Hospital

🇦🇺

Melbourne, Victoria, Australia

Melbourne Sleep Disorders Centre

🇦🇺

East Melbourne, Victoria, Australia

Hollywood Private Hospital (CVS)

🇦🇺

Nedlands, Western Australia, Australia

St. Anne's University Hospital BRNO

🇨🇿

Brno, Czechia

Rigshospitalet

🇩🇰

Copenhagen, Denmark

Bispebjerg Hospital

🇩🇰

Copenhagen, Denmark

Cardiologist Dr. Papola

🇫🇷

Amneville, France

Glostrup Hospital

🇩🇰

Glostrup, Denmark

Århus Universitets Hospital

🇩🇰

Århus C, Denmark

Århus Universitets Hospital Skejby

🇩🇰

Århus N, Denmark

Centre Hospitalier de Béziers

🇫🇷

Beziers, France

Centre Hospitalier de Cannes

🇫🇷

Cannes, France

CH Montbeliard

🇫🇷

Montbeliard, France

CH Intercommunal André Grégoire

🇫🇷

Montreuil, France

Clinique les Fleurs

🇫🇷

Ollioules, France

CHU Tenon

🇫🇷

Paris, France

CHU de Poitiers

🇫🇷

Poitiers, France

Polyclinique Saint-Laurent

🇫🇷

Rennes, France

CH Lemire - St Avold

🇫🇷

Saint Avold, France

CHU de Rouen, Hopital de Bois Guillaume

🇫🇷

Rouen, France

CHU Toulouse, Hopital Larrey

🇫🇷

Toulouse, France

CH de St Dié des Vosges

🇫🇷

St Dié des Vosges, France

CHU de Saint-Etienne, Hopital Nord

🇫🇷

Saint- Etienne, France

Ch St. Nicolas

🇫🇷

Verdun, France

CHU Toulouse, Hopital de Rangueil

🇫🇷

Toulouse, France

CH Trouville

🇫🇷

Trouville, France

DRK Krankenhaus

🇩🇪

Alzey, Germany

Gemeinschaftspraxis Weiß / Dr. Heesing

🇩🇪

Arnsberg, Germany

Praxis Dr. Bauer

🇩🇪

Bad Mergentheim, Germany

Herz- und Diabeteszentrum NRW

🇩🇪

Bad Oeynhausen, Germany

Oberlausitz-Kliniken gGmbH

🇩🇪

Bautzen, Germany

Kardiologie Brühl

🇩🇪

Brühl, Germany

Gemeinschaftspraxis Groß-Ziethener Chaussee

🇩🇪

Berlin, Germany

Herzzentrum Brandenburg

🇩🇪

Bernau, Germany

Kardiologie Gemeinschaftspraxis Dres Tenholt&Metzger&Dexling

🇩🇪

Bochum, Germany

Klinikum Coburg GmbH

🇩🇪

Coburg, Germany

MVZ am Küchwald

🇩🇪

Chemnitz, Germany

Fachkrankenhaus Coswig

🇩🇪

Coswig, Germany

Carl-Thiem-Klinikum gGmbH

🇩🇪

Cottbus, Germany

Ambulantes Zentrum für Lungenkrankheiten&Schlafmedizin

🇩🇪

Cottbus, Germany

Kardiologische Praxis Dr. Lodde

🇩🇪

Dortmund, Germany

Kardiologische Praxis Dr. Wetzel

🇩🇪

Dortmund, Germany

Facharztzentrum Dresden-Neustadt GbR

🇩🇪

Dresden, Germany

Herzzentrum Universität Dresden

🇩🇪

Dresden, Germany

Praxis Dr. Hohensee

🇩🇪

Dresden, Germany

goMedus Gesundheitszentrum

🇩🇪

Düsseldorf, Germany

Evangelisches Krankenhaus

🇩🇪

Düsseldorf, Germany

Kardiologische Praxis Dr. Raff

🇩🇪

Düsseldorf, Germany

Florence-Nightingale Krankenhaus

🇩🇪

Düsseldorf, Germany

Kardiologie Oberkassel

🇩🇪

Düsseldorf, Germany

Gemeinschaftspraxis PD. Dr. Lankisch

🇩🇪

Düsseldorf, Germany

Fachärzte für Innere Medizin Dres Ritter, Richter, Mehrer, Kahl

🇩🇪

Emmendingen, Germany

Helios Klinikum Erfurt-Schlafmedizin

🇩🇪

Erfurt, Germany

Universitätsklinikum Erlangen

🇩🇪

Erlangen, Germany

Westdeutsches Herzzentrum, Universitätsklinikum Essen

🇩🇪

Essen, Germany

Schwerpunktpraxis Kardiologie Drs. Ophoff/Fritzsch

🇩🇪

Essen, Germany

Kardiologische Praxis Dr. Cord Müller

🇩🇪

Essen, Germany

Kardiologische Praxis Prof. Winter

🇩🇪

Essen, Germany

Elisabeth-Krankenhaus Essen

🇩🇪

Essen, Germany

Kath. Kliniken Essen / Philippusstift

🇩🇪

Essen, Germany

Praxis Dr. Tekiyeh

🇩🇪

Essen, Germany

Gemeinschaftspraxis Dres. Guckenbiehl

🇩🇪

Flonheim, Germany

Praxis Dr. Diedrichs

🇩🇪

Frechen, Germany

Gemeinschaftspraxis Dres. Böhmeke/Schmidt

🇩🇪

Gladbeck, Germany

Kardiologische Praxis Dr. Hug

🇩🇪

Günzburg, Germany

Gemeinschaftspraxis Dres. Subin/Lutter

🇩🇪

Hamburg, Germany

Universitätsklinikum Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

Praxis Dr. Hötte

🇩🇪

Hannover, Germany

Praxis Dr. Durak

🇩🇪

Heidelberg, Germany

Klinikum Hannover Oststadt-Heidehaus

🇩🇪

Hannover, Germany

Universitätsklinikum Heidelberg

🇩🇪

Heidelberg, Germany

Gemeinschaftspraxis Dr. Bruch

🇩🇪

Herne, Germany

St. Elisabeth-Hospital Herten gGmbH

🇩🇪

Herten, Germany

Kardiologische Praxis Dr. Siegfried Frickel

🇩🇪

Kempen, Germany

Gemeinschaftspraxis Dres. Heifer/Loster/Schernus

🇩🇪

Mannheim, Germany

Malteser Krankenhaus St.Hildegardis

🇩🇪

Köln, Germany

Prof. Franzen Institut

🇩🇪

Köln, Germany

Gemeinschaftspraxis Dres. Gysan/Heinzler/May

🇩🇪

Köln, Germany

Gemeinschaftspraxis Dr. Hilgedieck/Sava

🇩🇪

Lengerich, Germany

Universitätsklinikum Schleswig-Holstein Campus Lübeck-Schlaflabor

🇩🇪

Lübeck, Germany

Gemeinschaftspraxis für Herz & Gefäße

🇩🇪

Mannheim, Germany

Universitätsklinik Mannheim-Kardiologie

🇩🇪

Mannheim, Germany

Gemeinschaftspraxis Dres. Brandt / Jakobs

🇩🇪

Mannheim, Germany

Universitätsklinikum Gießen/Marburg Standort Marburg-Kardiologie

🇩🇪

Marburg, Germany

Universitätsklinikum Gießen / Marburg, Standort Marburg-Schlafmedizin

🇩🇪

Marburg, Germany

Praxis Dr. Schnabel

🇩🇪

Meissen, Germany

Praxis Für Kardiologie Dr. med. Menz

🇩🇪

Menden, Germany

Kardiologische Praxis Dr. Schön

🇩🇪

Mühldorf, Germany

Kardiologie am Rotkreuzplatz

🇩🇪

München, Germany

Lungenärzte am Rotkreuzplatz

🇩🇪

München, Germany

Klinik Augustinum München

🇩🇪

München, Germany

Gemeinschaftspraxis Dres. Wauer / Windstetter

🇩🇪

München, Germany

Kardiologische Praxis Dr. Herholz

🇩🇪

München, Germany

Praxis Dres. Böhme/Linke

🇩🇪

München, Germany

Praxis für Kardiologie Dr. med. Hewing

🇩🇪

Münster, Germany

Lukaskrankenhaus GmbH

🇩🇪

Neuss, Germany

Klinikum Nürnberg Nord

🇩🇪

Nürnberg, Germany

Kardiologische Praxis Dr. Gumbrecht

🇩🇪

Ochtrup, Germany

Kardiologische Praxis Dr. Wiethölter

🇩🇪

Radebeul, Germany

Praxis für Kardiologie Ratingen

🇩🇪

Ratingen, Germany

DRK Krankenhaus Mölln-Ratzeburg

🇩🇪

Ratzeburg, Germany

Krankenhaus Reinbek St. Adolf-Stift

🇩🇪

Reinbek, Germany

Praxis Dr. Fröhlich

🇩🇪

Ratingen, Germany

Gemeinschaftspraxis Dr. Weber/Dr. Feja

🇩🇪

Recklinghausen, Germany

Universitätsklinikum Regensburg

🇩🇪

Regensburg, Germany

Ambulantes Cardiovaskuläres Centrum

🇩🇪

Ravensburg, Germany

Knappschafts-Krankenhaus Recklinghausen

🇩🇪

Recklinghausen, Germany

Praxis Dr. Kestermann

🇩🇪

Rheine, Germany

Kardiologische Praxis Dr. Heinze

🇩🇪

Schwerte, Germany

Praxis Dr. Nebel

🇩🇪

Rheine, Germany

Praxis Dr. Hein

🇩🇪

Reinbek, Germany

Praxis Dr. Ebeling

🇩🇪

Schönefeld, Germany

Praxisgemeinschaft Cardio-Soest

🇩🇪

Soest, Germany

Klinikum Uelzen GmbH

🇩🇪

Uelzen, Germany

Herzklinik Ulm Dr. Haerer und Partner

🇩🇪

Ulm, Germany

Facharztzentrum Sonneberg

🇩🇪

Sonneberg, Germany

Katharinen Hospital Unna

🇩🇪

Unna, Germany

Stiftungsklinik Weißenhorn

🇩🇪

Weißenhorn, Germany

Praxis Dr. Gerritsen

🇩🇪

Waldkraiburg, Germany

Kardiologische Praxis Dr. Burkhard-Meier

🇩🇪

Viersen, Germany

Fachkliniken Wangen

🇩🇪

Wangen, Germany

Kardiologische Praxis Dr. Vrettos

🇩🇪

Witten, Germany

Evangel. Khs Zweibrücken

🇩🇪

Zweibrücken, Germany

Stavanger AS

🇳🇴

Stavanger, Norway

Specialistläkarmottagning Residenset AB

🇸🇪

Jönköping, Sweden

Sahlgrenska University Hospital / Östra

🇸🇪

Göteborg, Sweden

Linköping University Hospital

🇸🇪

Linköping, Sweden

Skaraborgs Hospital

🇸🇪

Lidköping, Sweden

Chesterfield Royal Hospital

🇬🇧

Chesterfield, United Kingdom

Brompton Hospital

🇬🇧

London, United Kingdom

Ospedale Regionale di Lugano

🇨🇭

Lugano, Switzerland

Royal Wolverhampton Hospitals NHS Trust

🇬🇧

Wolverhampton, United Kingdom

Freeman Hospital

🇬🇧

Newcastle, United Kingdom

Musgrove Park Hospital

🇬🇧

Taunton, United Kingdom

Castle Hill Hospital

🇬🇧

Cottingham, East Yorkshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath